Medtronic plc (BIT:1MDT)
84.13
+0.34 (0.41%)
Last updated: Mar 4, 2026, 1:03 PM CET
Medtronic Cash Flow Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 23, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
Net Income | 4,639 | 4,691 | 3,705 | 3,784 | 5,062 | 3,630 |
Depreciation & Amortization | 3,082 | 2,861 | 2,647 | 2,697 | 2,707 | 2,702 |
Stock-Based Compensation | 451 | 429 | 393 | 355 | 359 | 344 |
Other Adjustments | 529 | 117 | 526 | 170 | 107 | 265 |
Change in Receivables | -162 | -433 | -391 | -576 | -477 | -761 |
Changes in Inventories | -617 | -292 | -139 | -939 | -560 | 78 |
Changes in Accounts Payable | 289 | 209 | 391 | 696 | 213 | 531 |
Changes in Other Operating Activities | -927 | -538 | -345 | -148 | -65 | -549 |
Operating Cash Flow | 7,285 | 7,044 | 6,787 | 6,039 | 7,346 | 6,240 |
Operating Cash Flow Growth | -0.11% | 3.79% | 12.39% | -17.79% | 17.72% | -13.74% |
Capital Expenditures | -1,875 | -1,859 | -1,587 | -1,459 | -1,368 | -1,355 |
Purchases of Investments | -8,705 | -8,226 | -7,748 | -7,514 | -9,882 | -11,808 |
Proceeds from Sale of Investments | 8,222 | 8,495 | 7,441 | 7,343 | 9,692 | 11,345 |
Payments for Business Acquisitions | - | -98 | -211 | -1,867 | -91 | -994 |
Other Investing Activities | -148 | -249 | -261 | 4 | -10 | -54 |
Investing Cash Flow | -2,507 | -1,937 | -2,366 | -3,493 | -1,659 | -2,866 |
Short-Term Debt Issued | - | - | - | 2,284 | - | 2,789 |
Short-Term Debt Repaid | - | - | - | -2,279 | - | -2,853 |
Net Short-Term Debt Issued (Repaid) | - | - | - | 5 | - | -64 |
Long-Term Debt Issued | 1,747 | 3,209 | - | 5,409 | - | 7,172 |
Long-Term Debt Repaid | -2,930 | - | - | -6,012 | -1 | -7,367 |
Net Long-Term Debt Issued (Repaid) | -1,183 | 3,209 | - | -603 | -1 | -195 |
Issuance of Common Stock | 527 | 508 | 284 | 308 | 429 | 474 |
Repurchase of Common Stock | -874 | -3,235 | -2,138 | -645 | -2,544 | -652 |
Net Common Stock Issued (Repurchased) | -347 | -2,727 | -1,854 | -337 | -2,115 | -178 |
Common Dividends Paid | -3,628 | -3,589 | -3,666 | -3,616 | -3,383 | -3,120 |
Other Financing Activities | -548.5 | -1,254 | 1,070 | -409 | 163 | -579 |
Financing Cash Flow | -5,206 | -4,361 | -4,450 | -4,960 | -5,336 | -4,136 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 335 | 188 | -230 | 243 | -231 | 215 |
Net Cash Flow | -94 | 934 | -259 | -2,171 | 121 | -547 |
Free Cash Flow | 5,410 | 5,185 | 5,200 | 4,580 | 5,978 | 4,885 |
Free Cash Flow Growth | 4.34% | -0.29% | 13.54% | -23.39% | 22.38% | -18.87% |
FCF Margin | 15.25% | 15.46% | 16.07% | 14.67% | 18.87% | 16.22% |
Free Cash Flow Per Share | 4.20 | 4.02 | 3.91 | 3.44 | 4.42 | 3.61 |
Levered Free Cash Flow | 3,382 | 8,252 | 4,643 | 4,007 | 5,965 | 4,754 |
Unlevered Free Cash Flow | 4,983 | 5,346 | 4,906 | 4,716 | 6,204 | 5,586 |
Updated Jan 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.